ArticleMolecular oncology2014

Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model.

Sifeng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.